The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
Abstract α1‐adrenoceptor antagonists are widely used for hypertension (eg, doxazosin) and benign prostatic hypertrophy (BPH, eg, tamsulosin). Some antidepressants and antipsychotics have been reported to have α1 affinity. This study examined 101 clinical drugs and laboratory compounds to build a com...
Main Authors: | Richard G. W. Proudman, Andre S. Pupo, Jillian G. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.602 |
Similar Items
-
The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
by: Richard G.W. Proudman, et al.
Published: (2022-04-01) -
The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2022-10-01) -
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
by: Meredith Mihalopoulos, et al.
Published: (2020-08-01) -
Chemically homogenous compounds with antagonistic properties at all α1-adrenoceptor subtypes but not β1-adrenoceptor attenuate adrenaline-induced arrhythmia in rats
by: Karolina Pytka, et al.
Published: (2016-08-01) -
Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil
by: Yasushi Tanuma, et al.
Published: (2021-01-01)